on Theranexus (EPA:ALTHX)
Theranexus: Publication of voting rights and shares as of October 31, 2025
On November 7, 2025, Theranexus, a biopharmaceutical company specializing in rare neurological diseases, disclosed its share capital structure as of October 31, 2025. The total number of shares comprising its share capital is 9,439,752, with 10,517,908 theoretical voting rights. These figures comply with Articles L. 233-8 II of the French Commercial Code and 223-16 of the AMF General Regulation.
Theoretical voting rights include shares without voting rights. Theranexus, also listed on Euronext Growth in Paris, continues its progress in the field of innovative treatments for rare neurological diseases.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Theranexus news